ACE2 and COVID-19: Based on these observations, we postulate that overactivation of the Ang II/AT1R axis induced by ACE2 inhibition and its inhibitory effect on megalin expression could be behind the tubular proteinuria and development of subAKI observed in patients with COVID-19.